Can overdosing get you high??!

Can overdosing get you high??

I overdosed on some painkillers, some were over the counter some were prescription, and I'm feeling kinda... I don't know the word for it. Like shakey and dizzy and just weird... It feels good though. I've done this before with just Tylenol. I took like 4-5 of them and got a similar feeling. So am I getting high?

I'm 14 about to be 15 in a month and I have never used drugs before or OD'd on anything except that one time with Tylenol... Is this the feeling of being high? Is it possible to get high off painkillers? I took 3 Tylenol, 1 Bayer, 2 prescription drugs of one kind, and 1 or 2 (Can't remember.) prescrition drugs of another kind... And I think I took 1 more pill but I can't remember if I did or not and what it was if I did.

And I have another question: Are there any websites I can go to for help? I really want help because the after effects are like a punch in the face. Thanks.

4 months ago
Here is what is on the bottle of the prescrption drugs I took:

30 Tab TRAMADOL HCL 50MG
Generic for: ULTRAM TAB 50MG

ULTRACET TAB MCNEIL...(It's rubbed out the rest of the way)

DONT TAKE ANYTHING ELSE!!!!!!!!!
My 18 year old niece died last year from overdosing!!!!!!!!!
Talk to someone NOW or have someone take you to the ER.
If you cant, then drink ALOT of water~~~~~~~~call a poison control center and they can tell you what to do over the phone.
If you are looking for a HIGH, DONT PLEASE!!! DONT! do it with drugs. There are other ways to get high without drugs!
Please be careful. Even too much Tylenol can hurt your body.
The RX's you mentioned are very strong and should NEVER be taken together.
I hope you read this and consider what we are all saying to you.
Best of luck

SIDE EFFECTS
ULTRAM was administered to 550 patients during the double-blind or open-label extension periods in U.S. studies of chronic nonmalignant pain. Of these patients,375 were 65 years old or older. Table 2 reports the cumulative incidence rate of adverse reactions by 7, 30 and 90 days for the most frequent reactions (5% or more by 7 days).The most frequently reported events were in the central nervous system and gastrointestinal system. Although the reactions listed in the table are felt to be probably related to ULTRAM administration, the reported rates also include some events that may have been due to underlying disease or concomitant medication. The overall incidence rates of adverse experiences in these trials were similar for ULTRAM and the active control groups, TYLENOL® with Codeine #3 (acetaminophen 300 mg with codeine phosphate 30 mg),and aspirin 325 mg with codeine phosphate 30 mg, however, the rates of withdrawals due to adverse events appeared to be higher in the ULTRAM groups.

Table 2:Cumulative Incidence of Adverse Reactions for ULTRAM in Chronic Trials of Nonmalignant Pain (N = 427)


Up to 7 Days
Up to 30 Days
Up to 90 Days

Dizziness/Vertigo
26%
31%
33%

Nausea
24%
34%
40%

Constipation
24%
38%
46%

Headache
18%
26%
32%

Somnolence
16%
23%
25%

Vomiting
9%
13%
17%

Pruritus
8%
10%
11%

"CNS Stimulation"1
7%
11%
14%

Asthenia
6%
11%
12%

Sweating
6%
7%
9%

Dyspepsia
5%
9%
13%

Dry Mouth
5%
9%
10%

Diarrhea
5%
6%
10%

1 "CNS Stimulation" is a composite of nervousness, anxiety, agitation, tremor, spasticity, euphoria, emotional lability and hallucinations.

WARNINGS
Seizure Risk

Seizures have been reported in patients receiving ULTRAM within the recommended dosage range. Spontaneous post-marketing reports indicate that seizure risk is increased with doses of ULTRAM above the recommended range. Concomitant use of ULTRAM increases the seizure risk in patients taking:

· Selective serotonin reuptake inhibitors (SSRI antidepressants or anorectics),

· Tricyclic antidepressants (TCAs), and other tricyclic compounds (e.g., cyclobenzaprine, promethazine, etc.),or

· Other opioids.

Administration of ULTRAM may enhance the seizure risk in patients taking:

· MAO inhibitors (see also WARNINGS

· Use with MAO Inhibitors),

· Neuroleptics,or

· Other drugs that reduce the seizure threshold.

Risk of convulsions may also increase in patients with epilepsy, those with a history of seizures, or in patients with a recognized risk for seizure (such as head trauma, metabolic disorders, alcohol and drug withdrawal, CNS infections). In ULTRAM overdose, naloxone administration may increase the risk of seizure.

Anaphylactoid Reactions

Serious and rarely fatal anaphylactoid reactions have been reported in patients receiving therapy with ULTRAM. When these events do occur it is often following the first dose. Other reported allergic reactions include pruritus, hives, bronchospasm, angioedema, toxic epidermal necrolysis and Stevens-Johnson syndrome. Patients with a history of anaphylactoid reactions to codeine and other opioids may be at increased risk and therefore should not receive ULTRAM (see CONTRAINDICATIONS).

Respiratory Depression

Administer ULTRAM cautiously in patients at risk for respiratory depression. In these patients alternative non-opioid analgesics should be considered. When large doses of ULTRAM are administered with anesthetic medications or alcohol, respiratory depression may result. Respiratory depression should be treated as an overdose. If naloxone is to be administered, use cautiously because it may precipitate seizures (see WARNINGS, Seizure Risk and OVERDOSAGE).

Interaction With Central Nervous System (CNS) Depressants

ULTRAM should be used with caution and in reduced dosages when administered to patients receiving CNS depressants such as alcohol, opioids, anesthetic agents, narcotics, phenothiazines, tranquilizers or sedative hypnotics. ULTRAM increases the risk of CNS and respiratory depression in these patients.

Increased Intracranial Pressure or Head Trauma

ULTRAM should be used with caution in patients with increased intracranial pressure or head injury. The respiratory depressant effects of opioids include carbon dioxide retention and secondary elevation of cerebrospinal fluid pressure, and may be markedly exaggerated in these patients. Additionally, pupillary changes (miosis) from tramadol may obscure the existence, extent, or course of intracranial pathology. Clinicians should also maintain a high index of suspicion for adverse drug reaction when evaluating altered mental status in these patients if they are receiving ULTRAM.(See Respiratory Depression.)

Use in Ambulatory Patients

ULTRAM may impair the mental and or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. The patient using this drug should be cautioned accordingly.

Use With MAO Inhibitors and Serotonin Re-uptake Inhibitors

Use ULTRAM with great caution in patients taking monoamine oxidase inhibitors. Animal studies have shown increased deaths with combined administration. Concomitant use of ULTRAM with MAO inhibitors or SSRIs increases the risk of adverse events, including seizure and serotonin syndrome.

Withdrawal

Withdrawal symptoms may occur if ULTRAM is discontinued abruptly.(See DRUG ABUSE AND DEPENDENCE.) These symptoms may include: anxiety, sweating, insomnia, rigors, pain, nausea, tremors, diarrhea, upper respiratory symptoms, piloerection, and rarely hallucinations. Clinical experience suggests that withdrawal symptoms may be relieved by tapering the medication.

Physical Dependence and Abuse

ULTRAM may induce psychic and physical dependence of the morphine-type (µ-opioid) (see DRUG ABUSE AND DEPENDENCE). ULTRAM should not be used in opioid-dependent patients. ULTRAM has been shown to reinitiate physical dependence in some patients that have been previously dependent on other opioids. Dependence and abuse, including drug-seeking behavior and taking illicit actions to obtain the drug, are not limited to those patients with prior history of opioid dependence.

Risk of Overdosage

Serious potential consequences of overdosage with ULTRAM (tramadol hydrochloride tablets) are central nervous system depression, respiratory depression and death. In treating an overdose, primary attention should be given to maintaining adequate ventilation along with general supportive treatment (see OVERDOSAGE).

PRECAUTIONS
Acute Abdominal Conditions

The administration of ULTRAM may complicate